|
US2019381159A1
|
|
Doubly attenuated late liver stage malaria parasites and related compositions and methods
|
|
US2019016776A1
|
|
Tumor-specific IFNA secretion by car T-cells to reprogram the solid tumor microenvironment
|
|
US2017165207A1
|
|
Cysteamine in the treatment of fibrotic disease
|
|
US2016333377A1
|
|
Enhancing endonuclease based gene editing in primary cells
|
|
US2016131646A1
|
|
Detection and treatment of autoimmune disorders
|
|
US2017044240A1
|
|
CCR5 disruption of cells expressing anti-HIV chimeric antigen receptor (CAR) derived from broadly neutralizing antibodies
|
|
EP2219539A1
|
|
Dynamic nasal molding device
|
